Our study provides new insights on therapeutically pliable and aberrant epigenetic mechanisms in the molecular pathogenesis of NSCLC involving prevalent hypermethylation of the TBX2 subfamily of evolutionarily conserved transcription factors. This evidence concerns the gene TBX2 and non-small cell lung carcinoma.